Open comment allows key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication. It allows for greater transparency in the ASCO ...

ASCO’s patient education resources are reviewed by ASCO’s Patient Information Editorial Board, composed of 200+ medical, surgical, radiation, and pediatric oncologists; multidisciplinary members of ...

The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer. Founded in 1964, ...

Launched in 2016, this award program honors extraordinary women leaders in oncology and role models who have excelled as mentors and have demonstrated outstanding commitment to the development of the ...

ASCO® Guidelines Assistant is an interactive AI tool developed by ASCO and Google Cloud. The tool allows oncologists to quickly search and use ASCO Guidelines through a simple, intuitive chat. Quickly ...

To learn more about the ASCO guideline development process, access the full ASCO Guideline Methodology Manual. ASCO Clinical Practice Guidelines are evidence-based products based on a systematic ...

The exhibitor and advertiser policies establish the general standards ASCO and its affiliates apply to the activities of commercial firms and other organizations, including not-for-profit ...

ASCO provides numerous quality activities aimed at improving the standard of cancer care received by patients in the United States and around the world. ASCO Certified is a program that certifies ...

The American Society of Clinical Oncology (ASCO) has been notified of a recent safety notice for the drug Jubbonti (denosumab-bbdz) under the Food and Drug Administration’s Risk Evaluation and ...